glp 1 alcohol cessation GLP-1 Agonists for Use Disorder: UK Evidence and Guidance GLP-1s Hold Promise as Treatment

C tc dng ph khng

Based on my experience and conversations with other athletes, here is a decision framework: Microdosing may be right if you: Only need to lose 3-8kg to reach your target race weight Train at high volume (10+ hours/week) and cannot afford to compromise fueling Have a history of GI sensitivity during exercise Are preparing for a specific race and cannot risk GI disruption Want to use GLP-1 as a tool alongside an already-disciplined nutrition plan Standard dosing may be more appropriate if you: Have significant weight to lose (15kg+) and are not currently in peak training Are in an off-season or base-building phase with lower fueling demands Have tried microdosing without meaningful results after 8-12 weeks Have metabolic health concerns (pre-diabetes, insulin resistance) that require therapeutic doses The key principle: find the minimum effective dose for your situation

While direct evidence linking CYP51A1 to pyroptosis is currently lacking, its emerging role in shaping innate immune responses highlights the need to further investigate whether CYP51A1 functions as a metabolic checkpoint that fine-tunes inflammasome activation and pyroptotic outcomes in inflammatory diseases

When you don't have enough of these shuttles, your fat just sits around instead of turning into fuel

Risk factors point in the same direction

Similar to other diabetes medicines, taking metformin can cause hypoglycemia (low blood sugar levels)